Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders

BACKGROUND: Patients with inherited blood disorders (IBLD) have a high risk of hepatitis C virus (HCV) infection. The aim of this work was to assess the efficacy and safety of HCV direct-acting antiviral (DAA)-based treatment in patients with IBLD and chronic HCV infection. METHODS: Twenty-seven pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Isaac, Fourati, Slim, Ahmed-Belkacem, Abdelhakim, Rodriguez, Christophe, Scoazec, Giovanna, Donati, Flora, Soulier, Alexandre, Demontant, Vanessa, Poiteau, Lila, N’Debi, Mélissa, François, Murielle, Chevaliez, Stéphane, Pawlotsky, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2021
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734617/
https://www.ncbi.nlm.nih.gov/pubmed/33208686
http://dx.doi.org/10.1097/MEG.0000000000002003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734617/
https://www.ncbi.nlm.nih.gov/pubmed/33208686
http://dx.doi.org/10.1097/MEG.0000000000002003

Ejemplares similares